Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Albano

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Fertility and Sterility|February 13, 2001
Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelixM Ludwig, H Riethmüller-Winzen, R E Felberbaum, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|December 24, 1997
Long-acting gonadotropin-releasing hormone agonists in the differential diagnosis of male precocious pubertyM C Albano, A C Latronico, I J Arnhold, et al.
Fertility and Sterility|August 8, 1998
The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist CetrorelixC Albano, G Grimbizis, J Smitz, et al.
Human Reproduction (Oxford, England)|April 28, 2000
Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III studyR E Felberbaum, C Albano, M Ludwig, et al.
Biological Signals and Receptors|May 15, 2001
Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's diseaseM Ebadi, P Govitrapong, S Sharma, et al.
Archives of Gynecology and Obstetrics|September 14, 2000
Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproductionM Ludwig, R E Felberbaum, P Devroey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1996
The immunogenicity of influenza virus vaccine in solid organ transplant recipientsE A Blumberg, C Albano, T Pruett, et al.
Human Reproduction (Oxford, England)|July 1, 1996
Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cyclesF Ubaldi, C Albano, M Peukert, et al.
Food Chemistry|September 27, 2017
Techno-functional properties of tomato puree fortified with anthocyanin pigmentsC Gerardi, C Albano, N Calabriso, et al.
Human Reproduction (Oxford, England)|February 1, 1995
Embryo quality and pregnancy potential of fresh compared with frozen embryos--is freezing detrimental to high quality embryos?C E Selick, G E Hofmann, C Albano, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Fertility and Sterility|February 13, 2001
Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelixM Ludwig, H Riethmüller-Winzen, R E Felberbaum, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|December 24, 1997
Long-acting gonadotropin-releasing hormone agonists in the differential diagnosis of male precocious pubertyM C Albano, A C Latronico, I J Arnhold, et al.
Fertility and Sterility|August 8, 1998
The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist CetrorelixC Albano, G Grimbizis, J Smitz, et al.
Human Reproduction (Oxford, England)|April 28, 2000
Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III studyR E Felberbaum, C Albano, M Ludwig, et al.
Biological Signals and Receptors|May 15, 2001
Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's diseaseM Ebadi, P Govitrapong, S Sharma, et al.
Archives of Gynecology and Obstetrics|September 14, 2000
Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproductionM Ludwig, R E Felberbaum, P Devroey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1996
The immunogenicity of influenza virus vaccine in solid organ transplant recipientsE A Blumberg, C Albano, T Pruett, et al.
Human Reproduction (Oxford, England)|July 1, 1996
Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cyclesF Ubaldi, C Albano, M Peukert, et al.
Food Chemistry|September 27, 2017
Techno-functional properties of tomato puree fortified with anthocyanin pigmentsC Gerardi, C Albano, N Calabriso, et al.
Human Reproduction (Oxford, England)|February 1, 1995
Embryo quality and pregnancy potential of fresh compared with frozen embryos--is freezing detrimental to high quality embryos?C E Selick, G E Hofmann, C Albano, et al.
Pageof 10